Shorter Radiation Courses Become Standard Care for Localized Prostate Cancer in New Guideline Bioengineer.org
A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging signs of antitumor activity, according to a trial published in The Journal of Nuclear Medicine's Late-Breaking Fast Track.
Astellas Bets Up to $1.3 Billion on Cancer Drug Yet to Enter Human Trials Bloomberg.com
Black women diagnosed with hormone receptor–positive (HR+) breast cancer experience significantly worse outcomes than white women.
A personalized melanoma vaccine, called intismeran, could mark a major advance in cancer treatment. Last week, pharmaceutical companies Merck and Moderna announced clinical trial results showing the vaccine, combined with immunotherapy, reduced the risk of cancer returning or death by 42% compared with immunotherapy…
UT Dell Medicine launches in Austin with major focus on complex care, cancer treatment KEYE
Опухоль отступает чаще: новый препарат показал результат при тяжёлых формах рака эндометрия Правда.Ру
Rutgers Medical School Researcher Available to Discuss Study on Possible New Way to Fight Drug-Resistant Liver Cancer | Newswise Newswise
Why cancer researchers struggle to capture the patient voice Fred Hutchinson Cancer Center
Obesity touches countless lives across the country and can lead to many other health complications. From August 2021 to 2023, the prevalence of obesity in adults in the U.S. was more than 40%. Research published in Science Advances, led by scientists at VCU Massey Comprehensive Cancer Center, found that targeting fat…
Новый препарат заметно снижает риск смерти при раке матки Наука Mail
Кыргызстан расширяет возможности лечения детей с онкологическими заболеваниями EGOV.KG
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of hypofractionated radiation therapy for patients with localized prostate cancer. The guideline replaces ASTRO's 2018 recommendations and reflects a matured evidence base showing…
Alliance for Clinical Trials in Oncology Announced Phase III ShortStop HER2 Study Oncodaily